Table 2. Meta-analysis of the Survivin −31C/G polymorphism and cancer risk association.
Sample size | Test of association | Test of heterogeneity | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Polymorphism | Study | Case | Control | Na | OR (95% CI) | Z | P-value | Modelb | χ2 | Pc | I2 (%) |
CC vs GG | Overall | 1897 | 2018 | 14 | 1.59 (1.20–2.10) | 3.20 | 0.001 | R | 44.27 | <0.001 | 72.9 |
Ethnicity | |||||||||||
Asian | 1280 | 1353 | 7 | 1.67 (1.16–2.40) | 2.73 | 0.006 | R | 27.74 | <0.001 | 78.4 | |
European | 578 | 636 | 6 | 1.47 (0.85–2.55) | 1.36 | 0.173 | R | 14.59 | 0.006 | 72.6 | |
Cancer type | |||||||||||
Gastric cancer | 197 | 166 | 3 | 2.20 (0.71–6.88) | 1.36 | 0.173 | R | 10.51 | 0.005 | 81.0 | |
Esophageal cancer | 253 | 271 | 2 | 1.32 (0.51–3.46) | 0.57 | 0.568 | R | 6.34 | 0.012 | 84.2 | |
GC vs GG | Overall | 2514 | 3134 | 14 | 1.08 (0.90–1.28) | 0.80 | 0.421 | R | 25.69 | 0.012 | 53.3 |
Ethnicity | |||||||||||
Asian | 1656 | 2072 | 7 | 1.32 (0.87–1.48) | 0.92 | 0.358 | R | 18.40 | 0.005 | 67.4 | |
European | 820 | 1013 | 6 | 1.06 (0.87–1.29) | 0.60 | 0.548 | F | 6.24 | 0.182 | 35.9 | |
Cancer type | |||||||||||
Gastric cancer | 252 | 277 | 3 | 1.06 (0.74–1.53) | 0.34 | 0.736 | F | 4.66 | 0.097 | 57.1 | |
Esophageal cancer | 369 | 415 | 2 | 0.99 (0.74–1.31) | 0.09 | 0.925 | F | 0.00 | 0.947 | 0.0 | |
CC/GC vs GG | Overall | 3485 | 3964 | 14 | 1.23 (1.00–1.51) | 2.00 | 0.045 | R | 39.23 | <0.001 | 69.4 |
Ethnicity | |||||||||||
Asian | 2388 | 2714 | 7 | 1.32 (0.99–1.78) | 1.86 | 0.063 | R | 26.18 | <0.001 | 77.1 | |
European | 1050 | 1193 | 6 | 1.18 (0.85–1.65) | 0.98 | 0.328 | R | 11.97 | 0.018 | 66.6 | |
Cancer type | |||||||||||
Gastric cancer | 363 | 344 | 3 | 1.38 (0.62–3.08) | 0.79 | 0.429 | R | 9.48 | 0.009 | 78.9 | |
Esophageal cancer | 471 | 518 | 2 | 1.06 (0.81–1.38) | 0.39 | 0.696 | F | 0.65 | 0.421 | 0.0 | |
CC vs GG/GC | Overall | 3485 | 3964 | 14 | 1.51 (1.23–1.85) | 3.90 | <0.001 | R | 33.29 | 0.001 | 64.0 |
Ethnicity | |||||||||||
Asian | 2388 | 2714 | 7 | 1.50 (1.17–1.91) | 3.24 | 0.001 | R | 18.96 | 0.004 | 68.4 | |
European | 1050 | 1193 | 6 | 1.44 (0.91–2.29) | 1.55 | 0.120 | R | 12.45 | 0.014 | 67.9 | |
Cancer type | |||||||||||
Gastric cancer | 363 | 344 | 3 | 2.06 (0.91–4.66) | 1.74 | 0.083 | R | 7.06 | 0.029 | 71.7 | |
Esophageal cancer | 419 | 518 | 2 | 1.32 (0.50–3.50) | 0.57 | 0.571 | R | 8.30 | 0.004 | 87.9 |
Number of comparisons.
Random-effects model (R) was used when P-value for heterogeneity test <0.05; otherwise, fix-effects model (F) was used.
P-value of Q-test for heterogeneity test.
Bold values indicate significant difference.